{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:26:00Z","timestamp":1788402360936,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009010","name":"Novartis Pharmaceuticals UK Ltd Camberley","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi-Aventis US LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp &amp; Dohme UK Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"F Hoffmann-La Roche Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000381","name":"Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000381","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jns.2025.123409","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T23:53:09Z","timestamp":1738021989000},"page":"123409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Clinical and socio-demographic characteristics of people with multiple sclerosis at the time of diagnosis: Influences on outcome trajectories"],"prefix":"10.1016","volume":"470","author":[{"given":"Carolyn A.","family":"Young","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil","family":"Sharrack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh K.","family":"Chhetri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Harrower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Thorpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen L.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Tennant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu","family":"Tanasescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jns.2025.123409_bb0005","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.apmr.2017.07.004","article-title":"How do pain, fatigue, depressive, and cognitive symptoms relate to well-being and social and physical functioning in the daily lives of individuals with multiple sclerosis?","volume":"98","author":"Kratz","year":"2017","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"1","key":"10.1016\/j.jns.2025.123409_bb0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/jama.1995.03520250075037","article-title":"Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes","volume":"273","author":"Wilson","year":"1995","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jns.2025.123409_bb0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/CPJ.0000000000000449","article-title":"Identifying priority outcomes that influence selection of disease-modifying therapies in MS","volume":"8","author":"Day","year":"2018","journal-title":"Neurology Clinical practice."},{"issue":"3","key":"10.1016\/j.jns.2025.123409_bb0020","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/1545968320902126","article-title":"Position sense deficits at the lower limbs in early multiple sclerosis: clinical and neural correlates","volume":"34","author":"Iandolo","year":"2020","journal-title":"Neurorehabil. Neural Repair"},{"issue":"1","key":"10.1016\/j.jns.2025.123409_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.rehab.2021.101491","article-title":"Prevalence and patterns of subclinical motor and cognitive impairments in non-disabled individuals with early multiple sclerosis: a multicenter cross-sectional study","volume":"65","author":"Cattaneo","year":"2022","journal-title":"Ann. Phys. Rehabil. Med."},{"issue":"6","key":"10.1016\/j.jns.2025.123409_bb0030","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/qjmed\/hcx070","article-title":"Cognitive dysfunction in early multiple sclerosis: a review","volume":"111","author":"McNicholas","year":"2018","journal-title":"QJM"},{"issue":"6","key":"10.1016\/j.jns.2025.123409_bb0035","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/acn3.51262","article-title":"Sleep disturbance and memory dysfunction in early multiple sclerosis","volume":"8","author":"Sumowski","year":"2021","journal-title":"Annals of clinical and translational neurology."},{"issue":"3","key":"10.1016\/j.jns.2025.123409_bb0040","doi-asserted-by":"crossref","first-page":"146","DOI":"10.7224\/1537-2073.2012-053","article-title":"Natural history of multiple sclerosis symptoms","volume":"15","author":"Kister","year":"2013","journal-title":"Int J MS Care."},{"issue":"4","key":"10.1016\/j.jns.2025.123409_bb0045","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/13524585211023352","article-title":"Prevalence, co-occurrence, and trajectories of pain, fatigue, depression, and anxiety in the year following multiple sclerosis diagnosis","volume":"28","author":"Valentine","year":"2022","journal-title":"Mult. Scler."},{"issue":"9","key":"10.1016\/j.jns.2025.123409_bb0050","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1177\/13524585211069070","article-title":"Productivity loss among people with early multiple sclerosis: a Canadian study","volume":"28","author":"Rodriguez Llorian","year":"2022","journal-title":"Mult. Scler."},{"issue":"5","key":"10.1016\/j.jns.2025.123409_bb0055","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/1352458518763541","article-title":"Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis","volume":"25","author":"Graetz","year":"2019","journal-title":"Mult. Scler."},{"issue":"13","key":"10.1016\/j.jns.2025.123409_bb0060","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007190","article-title":"Socioeconomic status and disability progression in multiple sclerosis: a multinational study","volume":"92","author":"Harding","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2025.123409_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.101930","article-title":"Socioeconomic deprivation increases the risk of disability in multiple sclerosis patients","volume":"40","author":"Calocer","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"8","key":"10.1016\/j.jns.2025.123409_bb0070","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1177\/1352458508092263","article-title":"Comorbidity, socioeconomic status and multiple sclerosis","volume":"14","author":"Marrie","year":"2008","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2025.123409_bb0075","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3389\/fneur.2020.00851","article-title":"Comorbidity in multiple sclerosis","volume":"11","author":"Magyari","year":"2020","journal-title":"Front. Neurol."},{"issue":"8","key":"10.1016\/j.jns.2025.123409_bb0080","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1080\/14737175.2020.1746645","article-title":"A systematic review of morbidities suggestive of the multiple sclerosis prodrome","volume":"20","author":"Yusuf","year":"2020","journal-title":"Expert Rev. Neurother."},{"issue":"5","key":"10.1016\/j.jns.2025.123409_bb0085","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/1352458510392262","article-title":"The relationship between fatigue and other clinical features of multiple sclerosis","volume":"17","author":"Mills","year":"2011","journal-title":"Mult. Scler."},{"issue":"10","key":"10.1016\/j.jns.2025.123409_bb0090","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual. Life Res."},{"issue":"1","key":"10.1016\/j.jns.2025.123409_bb0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hec.3564","article-title":"Valuing health-related quality of life: an EQ-5D-5L value set for England","volume":"27","author":"Devlin","year":"2018","journal-title":"Health Econ."},{"issue":"11","key":"10.1016\/j.jns.2025.123409_bb0100","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1007\/s11136-023-03470-6","article-title":"Measuring disability in multiple sclerosis: the WHODAS 2.0","volume":"32","author":"Young","year":"2023","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.jns.2025.123409_bb0105","series-title":"Measuring Health and Disability Manual for WHO Disability Assessment Schedule","author":"\u00dcst\u00fcn","year":"2010"},{"issue":"6","key":"10.1016\/j.jns.2025.123409_bb0110","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr. Scand."},{"issue":"3","key":"10.1016\/j.jns.2025.123409_bb0115","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0033291798006667","article-title":"Development of the World Health Organization WHOQOL-BREF quality of life assessment","volume":"28","author":"The WHOQOL Group","year":"1998","journal-title":"Psychol. Med."},{"issue":"7","key":"10.1016\/j.jns.2025.123409_bb0120","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s11136-020-02463-z","article-title":"The WHOQOL-BREF: a modern psychometric evaluation of its internal construct validity in people with multiple sclerosis","volume":"29","author":"Pomeroy","year":"2020","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.jns.2025.123409_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2055217316642263","article-title":"The neurological sleep index: a suite of new sleep scales for multiple sclerosis","volume":"2","author":"Mills","year":"2016","journal-title":"Multiple Sclerosis Journal - Experimental, Translational and Clinical."},{"key":"10.1016\/j.jns.2025.123409_bb0130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1477-7525-8-22","article-title":"Development of a patient reported outcome scale for fatigue in multiple sclerosis: the neurological fatigue index (NFI-MS)","volume":"8","author":"Mills","year":"2010","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.jns.2025.123409_bb0135","series-title":"Probabilistic Models for some Intelligence and Attainment Tests","author":"Rasch","year":"1980"},{"issue":"1","key":"10.1016\/j.jns.2025.123409_bb0140","first-page":"1317","article-title":"Rasch analysis of repeated measures","volume":"25","author":"Mallinson","year":"2011","journal-title":"Rasch Measurement Transactions."},{"key":"10.1016\/j.jns.2025.123409_bb0145","doi-asserted-by":"crossref","first-page":"1208670","DOI":"10.3389\/fresc.2023.1208670","article-title":"Application of the Rasch measurement model in rehabilitation research and practice: early developments, current practice, and future challenges","volume":"4","author":"Tennant","year":"2023","journal-title":"Front Rehabil Sci."},{"key":"10.1016\/j.jns.2025.123409_bb0150","unstructured":"Ministry of Housing CLG. English indices of deprivation 2019 UK: UK Government; 2019 [Available from: https:\/\/www.gov.uk\/government\/statistics\/english-indices-of-deprivation-2010 https:\/\/www.gov.uk\/government\/statistics\/english-indices-of-deprivation-2019."},{"key":"10.1016\/j.jns.2025.123409_bb0155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","article-title":"Group-based trajectory modeling in clinical research","volume":"6","author":"Nagin","year":"2010","journal-title":"Annu. Rev. Clin. Psychol."},{"issue":"2\u20133","key":"10.1016\/j.jns.2025.123409_bb0160","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000360229","article-title":"Group-based trajectory modeling: an overview","volume":"65","author":"Nagin","year":"2014","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.jns.2025.123409_bb0165","series-title":"Stata Statistical Software","author":"StataCorp.","year":"2017"},{"issue":"3","key":"10.1016\/j.jns.2025.123409_bb0170","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1207\/S15324796ABM2603_02","article-title":"Classification and regression tree analysis in public health: methodological review and comparison with logistic regression","volume":"26","author":"Lemon","year":"2003","journal-title":"Ann. Behav. Med."},{"issue":"6","key":"10.1016\/j.jns.2025.123409_bb0175","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s40273-018-0628-3","article-title":"Comparing the UK EQ-5D-3L and English EQ-5D-5L value sets","volume":"36","author":"Mulhern","year":"2018","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"10.1016\/j.jns.2025.123409_bb0180","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s11136-022-03214-y","article-title":"Validation of the EQ-5D-5L and psychosocial bolt-ons in a large cohort of people living with multiple sclerosis in Australia","volume":"32","author":"Campbell","year":"2023","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.jns.2025.123409_bb0185","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2024-333632","article-title":"Long-term disability trajectories in multiple sclerosis: a group-based trajectory analysis of the AusLong cohort.J","author":"Zarghami","year":"2024","journal-title":"Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.jns.2025.123409_bb0190","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1177\/1352458517703800","article-title":"Long-term disability trajectories in primary progressive MS patients: a latent class growth analysis","volume":"24","author":"Signori","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2025.123409_bb0195","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.msard.2016.08.004","article-title":"Heterogeneous depression trajectories in multiple sclerosis patients","volume":"9","author":"Gunzler","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.jns.2025.123409_bb0200","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jval.2022.07.005","article-title":"Quality-adjusted life expectancy norms for the English population","volume":"26","author":"McNamara","year":"2023","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jns.2025.123409_bb0205","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.respe.2009.10.009","article-title":"The WHOQOL-BREF questionnaire: French adult population norms for the physical health, psychological health and social relationship dimensions","volume":"58","author":"Baumann","year":"2010","journal-title":"Revue d\u2019epidemiologie et de sante publique."},{"issue":"9","key":"10.1016\/j.jns.2025.123409_bb0210","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.apmr.2009.03.018","article-title":"Physical and cognitive functioning after 3 years can be predicted using information from the diagnostic process in recently diagnosed multiple sclerosis","volume":"90","author":"de Groot","year":"2009","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"8","key":"10.1016\/j.jns.2025.123409_bb0215","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1212\/WNL.0000000000001285","article-title":"Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis","volume":"84","author":"Schoonheim","year":"2015","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jns.2025.123409_bb0220","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-058506","article-title":"FutureMS cohort profile: a Scottish multicentre inception cohort study of relapsing-remitting multiple sclerosis","volume":"12","author":"Kearns","year":"2022","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.jns.2025.123409_bb0225","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/jama.2020.2278","article-title":"Using latent class analysis to identify hidden clinical phenotypes","volume":"324","author":"Mori","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2025.123409_bb0230","article-title":"Progression to refractory status epilepticus: a machine learning analysis by means of classification and regression tree analysis","volume":"161","author":"Meletti","year":"2024","journal-title":"Epilepsy & behavior\u202f: E&B."},{"key":"10.1016\/j.jns.2025.123409_bb0235","doi-asserted-by":"crossref","first-page":"1101521","DOI":"10.3389\/fneur.2023.1101521","article-title":"Good multiple sclerosis (MS) care and how to get there in Canada: perspectives of Canadian healthcare providers working with persons with MS","volume":"14","author":"Petrin","year":"2023","journal-title":"Front. Neurol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25000267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25000267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T18:32:51Z","timestamp":1740421971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X25000267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":47,"alternative-id":["S0022510X25000267"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2025.123409","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and socio-demographic characteristics of people with multiple sclerosis at the time of diagnosis: Influences on outcome trajectories","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2025.123409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123409"}}